anti-thrombotic drugs
Showing 1 - 25 of >10,000
Surgery, Perioperative/Postoperative Complications Trial in Dallas
Active, not recruiting
- Surgery
- Perioperative/Postoperative Complications
-
Dallas, Texas
- +1 more
May 9, 2022
Vascular Diseases Trial in Paris (use of digital tablet)
Terminated
- Vascular Diseases
- use of digital tablet
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Oct 31, 2022
Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)
Not yet recruiting
- Coronary Artery Ectasia
- Rivaroxaban 2.5 Mg Oral Tablet twice daily
- +2 more
- (no location specified)
Jan 30, 2023
Healthy Trial in Philadelphia (Celecoxib, Naproxen, Placebo)
Terminated
- Healthy
- Celecoxib
- +2 more
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Oct 20, 2022
Mild Pre-eclampsia Trial in Assiut (methyldopa tablets 250mg, methyldopa tablets 250mg + foot reflexology)
Not yet recruiting
- Mild Pre-eclampsia
- methyldopa tablets 250mg
- methyldopa tablets 250mg + foot reflexology
-
Assiut, Assuit, EgyptAbeer Ali Ahmed Mansour
Jun 9, 2023
Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)
Recruiting
- Macular Edema Due to Type 2 Diabetes Mellitus
- Anti-VEGF
- subthreshold micropulse laser
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023
Atrial Fibrillation, Left Atrial Appendage Occlusion, Silent Cerebral Embolism Trial in Nanjing (aspirin and clopidogrel,
Recruiting
- Atrial Fibrillation
- +2 more
- aspirin and clopidogrel
- Rivaroxaban
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jan 3, 2023
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19
Completed
- Post-COVID-19 Syndrome
- Lung Fibrosis
- Corticosteroids alone
- +3 more
-
Mansoura, Dakahlia, EgyptMansoura University
Dec 11, 2022
Risk of NSAIDs on Anastomotic Leak for Rectal Surgery
Recruiting
- Anastomotic Leak
- Anti-Inflammatory Agents, Non-Steroidal
-
Chongqing, None Selected, ChinaArmy Medical Center
Nov 24, 2023
Acute Ischemic Stroke Trial in Houston (Thrombolytic Agent)
Recruiting
- Acute Ischemic Stroke
- Thrombolytic Agent
-
Houston, TexasMichael E. DeBakey VA Medical Center
Jun 8, 2022
Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)
Recruiting
- Post-endodontic Pain
- Cryotherapy
- +2 more
-
Cairo, EgyptAin Shams University
Oct 13, 2023
Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- +2 more
- (no location specified)
Aug 8, 2022
Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)
Recruiting
- Prostate Cancer
- +2 more
- Ibuprofen or Naproxen
- PSA test
-
Albany, New YorkAlbany Medical Center
Nov 29, 2022
Active Pharmacovigilance of Anti-cancer Medicines
Recruiting
- Oncology
- +2 more
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Apr 11, 2023
Unresectable Hepatocellular Carcinoma Trial (Huaier granule, Atezolizumab + Bevacizumab, Camrelizumab+Apatinib)
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- Huaier granule
- +3 more
- (no location specified)
Dec 20, 2022
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Glaucoma Trial in Glostrup (Voltaren Ophtha 1 mg/ml, GSK, Monopex 1 mg/ml, Théa)
Active, not recruiting
- Glaucoma
- Voltaren Ophtha 1 mg/ml, GSK
- Monopex 1 mg/ml, Théa
-
Glostrup, Capital Region,, DenmarkDepartment of Ophthalmology
Oct 25, 2022
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Drug Resistant Epilepsy Trial in Jakarta Pusat, Jakarta (Valproic acid, Carbamazepin, Phenytoin)
Recruiting
- Drug Resistant Epilepsy
- Valproic acid
- +5 more
-
Jakarta Pusat, Jakarta, Indonesia
- +2 more
Jan 14, 2023
Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's
Recruiting
- Stellate Ganglion
- Parkinson Disease
- Treatment (Stellate ganglion block;Oral standard anti-Parkinson's drugs)
- Treatment (Oral standard anti-Parkinson's drugs)
-
Guangzhou, Guangdong, ChinaZhujiang Hospiatal
Oct 26, 2023
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
Not yet recruiting
- HIV Infection
- Anti-HIV Agents
- (no location specified)
Nov 4, 2022
Type2 Diabetes, Coronary Heart Disease Trial in Portugal (Exposure to Anti-thrombotic treatment agents and glucose lowering
Active, not recruiting
- Type2 Diabetes Mellitus
- Coronary Heart Disease
- Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
-
Amadora, Lisbon, Portugal
- +11 more
Oct 26, 2021
Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)
Recruiting
- Atrial Fibrillation
- NOAC monotherapy
- Dual therapy with apixaban and clopidogrel
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Sep 10, 2021
Parkinson's Disease, Overactive Bladder, Onabotulinumtoxin A Trial in Guangzhou (oral anti-Parkinson drugs and injection of
Recruiting
- Parkinson's Disease
- +2 more
- oral anti-Parkinson drugs and injection of botulinum toxin
- oral anti-Parkinson's drugs
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Aug 16, 2023
Healthy Trial in Philadelphia (Blood draw)
Active, not recruiting
- Healthy
- Blood draw
-
Philadelphia, PennsylvaniaThe Clinical Translational Research Center (CTRC) at the Hospita
Aug 16, 2022